![]() Ab Initio Biotherapeutics Ab Initio is engaged in identifying therapeutic antibodies that activate and inactivate G-protein coupled receptors. | ![]() Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ||||
Founding Date | Founding Date 2015 | Founding Date 1965 | Founding Date 1951 | Founding Date 2001 | Founding Date 1916 |
Type | Type Subsidiary | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK | Locations Brussel, BE HQ Buggenhout, BE | Locations Kunming, CN HQ | Locations Parkville, AU HQ King Of Prussia, US |
Employees | Employees 1 | Employees 2,4241% increase | Employees 6761% increase | Employees 2,388 | Employees 32,698 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.3 b | Valuation ($) 95.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $15.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods $6.5b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit $9.1b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ¥125.2m (FY, 2025) | Net income $3.1b (FY, 2025) |
The Searle Company is a pharmaceutical company.
View companyPlasma Industries is a pharmaceutical company.
View company
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View companyCSL is a biotech company providing life-saving medicines.
View company